Related Experiment Video
Updated: Jun 24, 2026

An In vitro Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection
Published on: December 10, 2013
Surfactant protein C-deficient mice are susceptible to respiratory syncytial virus infection
Stephan W Glasser1, Teah L Witt, Albert P Senft
1Division of Pulmonary Biology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio 45229-3039, USA. steve.glasser@cchmc.org
Abstract:
Patients with mutations in the pulmonary surfactant protein C (SP-C) gene develop interstitial lung disease and pulmonary exacerbations associated with viral infections including respiratory syncytial virus (RSV). Pulmonary infection with RSV caused more severe interstitial thickening, air space consolidation, and goblet cell hyperplasia in SP-C-deficient (Sftpc(-/-)) mice compared with SP-C replete mice. The RSV-induced pathology resolved more slowly in Sftpc(-/-) mice with lung inflammation persistent up to 30 days postinfection. Polymorphonuclear leukocyte and macrophage counts were increased in the bronchoalveolar lavage (BAL) fluid of Sftpc(-/-) mice. Viral titers and viral F and G protein mRNA were significantly increased in both Sftpc(-/-) and heterozygous Sftpc(+/-) mice compared with controls. Expression of Toll-like receptor 3 (TLR3) mRNA was increased in the lungs of Sftpc(-/-) mice relative to Sftpc(+/+) mice before and after RSV infection. Consistent with the increased TLR3 expression, BAL inflammatory cells were increased in the Sftpc(-/-) mice after exposure to a TLR3-specific ligand, poly(I:C). Preparations of purified SP-C and synthetic phospholipids blocked poly(I:C)-induced TLR3 signaling in vitro. SP-C deficiency increases the severity of RSV-induced pulmonary inflammation through regulation of TLR3 signaling.
Insights
Pulmonary surfactant protein C (SP-C) deficiency worsens respiratory syncytial virus (RSV) lung inflammation by increasing Toll-like receptor 3 (TLR3) signaling. This leads to more severe lung damage and slower recovery in SP-C deficient mice.
Area of Science:
- Pulmonary medicine
- Immunology
- Genetics
Background:
- Mutations in the pulmonary surfactant protein C (SP-C) gene are linked to interstitial lung disease and severe respiratory infections.
- Respiratory syncytial virus (RSV) infections can cause significant pulmonary complications in individuals with SP-C gene mutations.
Purpose of the Study:
- To investigate the impact of SP-C deficiency on the severity and resolution of RSV-induced lung inflammation.
- To explore the role of Toll-like receptor 3 (TLR3) signaling in SP-C deficient mice during RSV infection.
Main Methods:
- Comparison of RSV-induced lung pathology in SP-C deficient (Sftpc(-/-)) and wild-type (Sftpc(+/+)) mice.
- Analysis of bronchoalveolar lavage (BAL) fluid for inflammatory cell counts and viral loads.
- Measurement of viral F and G protein mRNA and Toll-like receptor 3 (TLR3) mRNA expression in lung tissue.
- In vitro experiments assessing the effect of SP-C on poly(I:C)-induced TLR3 signaling.
Main Results:
- SP-C deficient mice exhibited more severe interstitial thickening, air space consolidation, and goblet cell hyperplasia after RSV infection.
- RSV-induced lung pathology resolved more slowly in SP-C deficient mice, with persistent inflammation.
- Increased viral titers and viral F and G protein mRNA were observed in SP-C deficient and heterozygous mice.
- Upregulated TLR3 mRNA expression and heightened inflammatory cell response to TLR3 ligand were noted in SP-C deficient mice.
- Purified SP-C and synthetic phospholipids inhibited poly(I:C)-induced TLR3 signaling in vitro.
Conclusions:
- SP-C deficiency exacerbates RSV-induced pulmonary inflammation and pathology.
- The mechanism involves the dysregulation of TLR3 signaling pathways.
- SP-C plays a protective role in modulating the innate immune response to viral lung infections.
More Related Videos
Related Concept Videos
Respiratory Syncytial Virus Disease
Breathing
Cytomegalovirus Disease
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...

